Search Results

Design, synthesis, and biological evaluation of phenylisoxazole-based histone deacetylase inhibitors.

• Authors : Qin, Xiaofei^1,2,3,4,5 (AUTHOR) ; Han, Meng^1,2,3,4,5 (AUTHOR); Hu, Peng^1,2,3,4,5 (AUTHOR)

• Source: PLoS ONE. 11/5/2025, Vol. 20 Issue 11, p1-14. 14p.

Record details

Histone deacetylase inhibitors sensitize glioblastoma models to temozolomide and reprogram immunosuppressive myeloid cells.

• Authors : Tehrani, Golnaz Asaadi¹ (AUTHOR); Kubick, Rebecca N.² (AUTHOR); Zarodniuk, Maksym¹ (AUTHOR)

• Source: Scientific Reports. 10/21/2025, Vol. 15 Issue 1, p1-13. 13p.

Record details

Adverse drug reaction profiles of histone deacetylase inhibitors.

• Authors : Begum, Ruqayyah¹ (AUTHOR); Parsons, Jason L.² (AUTHOR); Jones, Alan M.¹ (AUTHOR)

• Source: Scientific Reports. 10/14/2025, Vol. 15 Issue 1, p1-12. 12p.

Record details

Corn Starch Nanoparticles as an Effective and Nontoxic Nanocarrier Involving Histone Deacetylase Inhibitors for Smart Drug Delivery.

• Authors : Badritdinova, Matluba¹ ; Yuldasheva, Dilnavoz¹; Suvanova, Kamola²

• Source: Journal of Nanostructures. Autumn2025, Vol. 15 Issue 4, p2282-2292. 10p.

Record details

Ferrocene Derivatives as Histone Deacetylase Inhibitors: Synthesis and Biological Evaluation.

• Authors : Angelova, Rostislava¹ (AUTHOR); Stavrakov, Georgi^1,2 (AUTHOR)

• Source: Organics. Mar2025, Vol. 6 Issue 1, p4. 17p.

Record details

Combinations of histone deacetylase inhibitors extend chronological lifespan in S. cerevisiae

• Authors : Wherry, Owen H.

Subjects: Other Quantitative Biology

Record details

Some histone deacetylase inhibitors protect against dextran sulphate sodium-induced hepatotoxicity in mice.

• Authors : Coşkun, Cansu Özal¹ ; Arda, Pelin²; Özsoy, Nurten³

• Source: Istanbul Journal of Pharmacy. Dec2024, Vol. 54 Issue 3, p368-377. 10p.

Record details

Recent Insights into the Creation of Histone Deacetylase Inhibitors for the Treatment of Human Diseases.

• Authors : Yudaev, Pavel¹ (AUTHOR) ; Aleksandrova, Yulia¹ (AUTHOR); Neganova, Margarita¹ (AUTHOR)

• Source: International Journal of Molecular Sciences. Sep2025, Vol. 26 Issue 17, p8629. 34p.

Record details

Metformin sensitizes triple-negative breast cancer to histone deacetylase inhibitors by targeting FGFR4.

• Authors : Gu Z; Department of Breast Surgery, Shanghai Key Laboratory of Maternal-Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, No. 2699 West Gao-Ke Road, Shanghai, 201204, China.; Ye F

Subjects: Metformin*/Metformin*/Metformin*/pharmacology ; Metformin*/Metformin*/Metformin*/therapeutic use ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy

• Source: Journal of biomedical science [J Biomed Sci] 2025 Mar 17; Vol. 32 (1), pp. 36. Date of Electronic Publication: 2025 Mar 17.Publisher: BioMed Central Country of Publication: England NLM ID: 9421567 Publication Model: Electronic Cited Medium: Internet ISSN: 1423-0127

Record details

Computationally Guided Design, Synthesis, and Evaluation of Novel Non-Hydroxamic Histone Deacetylase Inhibitors, Based on N -Trifluoroacetamide as a Zinc-Binding Group, Against Breast Cancer.

• Authors : Morales-Herrejón, Gerardo¹ (AUTHOR); García-Vázquez, Juan Benjamín^1,2 (AUTHOR); Fernández-Pomares, Cynthia^1,3 (AUTHOR)

• Source: Pharmaceuticals (14248247). Mar2025, Vol. 18 Issue 3, p351. 29p.

Record details